Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Adult Congenital Heart Disease Registry (QuERI)

Study:

Adult Congenital Heart Disease Quality Enhancement Research Initiative

Rationale:

n/a

Purpose:

Multi-center, observational, U.S.-based longitudinal program. Data will be collected prospectively for 3 years. Individual physician feedback will be provided on data collected with the purpose of improving the management of patients - quality enhancement research initiative (QuERI) process from adult patients enrolled with a history of repaired Congenital Heart Disease (CHD).

Study Status: Recruiting

Recruiting:
Richard Krasuski, MD 216-445-7430 krasusr@ccf.org

Condition Intervention Phase
Pulmonary Arterial Hypertension
Congenital Heart Disease
Other: observational N/A

Verified by Actelion January, 2014

Sponsored by: Actelion
Information provided by: Actelion
ClinicalTrials.gov identifier: NCT01659411

Study Type: Interventional

Study Design: Observational Model: Cohort, Time Perspective: Prospective

The Cleveland Clinic Adult Congenital Heart Disease Center
Cleveland, Ohio 44195
United States

Michael J Landzberg, MD., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site